{
    "medicine_id": "0e0b4152fc1479163bcd46371ae51e0914ac1408",
    "platform_id": "DB01284",
    "metadata": {
        "name": "Cortrosyn 0 25 mg 1mL Injection powder lyophilized for solution",
        "composition": "0 25 mg 1mL Tetracosactide",
        "clinical_particulars": {
            "therapeutic_indications": "For use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Cosyntropin exhibits the full corticosteroidogenic activity of natural ACTH Various studies have shown that the biologic activity of ACTH resides in the N terminal portion of the molecule and that the 1 20 amino acid residue is the minimal sequence retaining full activity Partial or complete loss of activity is noted with progressive shortening of the chain beyond 20 amino acid residue For example the decrement from 20 to 19 results in a 70 loss of potency The pharmacologic profile of Cosyntropin is similar to that of purified natural ACTH It has been established that 0 25 mg of Cosyntropin will stimulate the adrenal cortex maximally and to the same extent as 25 units of natural ACTH Cosyntropin has less immunogenic activity than ACTH because the amino acid sequence having most of the antigenic activity of ACTH i e amino acids 25 39 is not present in cosyntropin The extra adrenal effects which natural ACTH and Cosyntropin have in common include increased melanotropic activity increased growth hormone secretion and an adipokinetic effect These are considered to be without physiological or clinical significance",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00313",
                        "description": "Tetracosactide may increase the hepatotoxic activities of Valproic acid"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Lorazepam"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Butalbital"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Phenytoin"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Topiramate"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Pentobarbital"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Trimethadione"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Clobazam"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Secobarbital"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Metharbital"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Methohexital"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Mephenytoin"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Ethosuximide"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Thiopental"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Paramethadione"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Clorazepic acid"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Tizanidine"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Riluzole"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Ethotoin"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Oxcarbazepine"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Primidone"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Acetazolamide"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Diazepam"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Phensuximide"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Progabide"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Methylphenobarbital"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Tiagabine"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Zonisamide"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Felbamate"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Zaleplon"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Gabapentin"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Rufinamide"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Perampanel"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Cannabidiol"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The risk or severity of liver damage can be increased when Tetracosactide is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Tetracosactide may increase the hepatotoxic activities of Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The serum concentration of Nitrazepam can be increased when it is combined with Tetracosactide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}